Posted inBiotechnology
Study Warns of Hidden Sleep Crisis Among Workers Over 50
Sleep problems may be far more widespread among mid-to-later life workers than clinicians and policymakers assumed, according to a year-long…
Posted inBiotechnology
Survey Reveals Gaps in Fungal Diagnostics and Antifungal Access in Latin America
A multinational survey spanning Latin America and the Caribbean has spotlighted a persistent bottleneck in the region’s fight against invasive…
Posted inBiotechnology
GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ’s backyard
GSK has unveiled an ambitious three-year plan to divert resources to its late-stage R&D programs and shift its research headquarters—but…
Posted inBiotechnology
Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3 trial
Atea Pharmaceuticals’ hepatitis C prospect has matched Gilead’s Epclusa in a phase 3 trial, keeping the biotech barreling toward a…
Posted inResearch
Acrosian debuts as AI-focused biometrics CRO
The founders of contract research organization Quartesian have reunited to form Acrosian, a CRO designed to be purpose-built for the…
Posted inMedical Technology
Guardant Health taps Patrick Dempsey for emotional colorectal cancer awareness video
Colorectal cancer blood test maker Guardant Health has teamed up with “Grey’s Anatomy” star Patrick Dempsey for a new, highly…
Posted inBiotechnology
GSK partner Hansoh reports another phase 3 win for priority ADC
Hansoh Pharmaceutical has guided its GSK-partnered, B7-H3-directed antibody-drug conjugate to another phase 3 win in China.
Posted inBiotechnology
Clonal Division Memory in Humans Splits Between Healthy Blood Formation and AML
A new study published in Nature Communications reports that the history of how human blood cells divide leaves behind a…
Posted inBiotechnology
New initiative aims to secure AI systems used in scientific research
Artificial intelligence is becoming a core instrument of scientific discovery, but it introduces a vulnerability that conventional cybersecurity often misses:…
Posted inBiotechnology
Houston Methodist Researchers Create Biodegradable Implant for Targeted Cancer Immunotherapy
Houston Methodist Research Institute scientists have unveiled a biodegradable implant intended to deliver cancer-fighting immunotherapy drugs directly within tumors for…